Faron leading the way in macrophage guided immunotherapy

Project description

An innovative treatment that breaks immune tolerance in cancer

Fields of science

• medical and health sciences › clinical medicine › oncology
• medical and health sciences › basic medicine › immunology › immunotherapy

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-EIC-SMEInst-2018-2020-3

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

FARON PHARMACEUTICALS OY

Net EU contribution

€ 2 500 000,00

Address

Joukahaisenkatu 6
20520 Turku
Finland

Region

Manner-Suomi › Etelä-Suomi › Varsinais-Suomi

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Non-EU contribution

€ 2 044 008,50